| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 33 |
| 1 | LETROZOLE TABLETS | 30 |
| 2 | DENOSUMAB | 29 |
| 3 | FULVESTRANT | 29 |
| 4 | EXEMESTANE | 24 |
| 5 | CAPECITABINE | 19 |
| 6 | ANASTROZOLE | 17 |
| 7 | PALBOCICLIB | 17 |
| 8 | ZOLEDRONIC ACID | 17 |
| 9 | ANASTROZOLE TABLETS | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADO-TRASTUZUMAB EMTANSINE | 11 | 0.0013 |
| 1 | EXEMESTANE | 24 | 0.0011 |
| 2 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 3 | GOSERELIN | 13 | 0.0010 |
| 4 | EVEROLIMUS TABLETS | 15 | 0.0009 |
| 5 | FULVESTRANT | 29 | 0.0009 |
| 6 | SODIUM CITRATE | 1 | 0.0008 |
| 7 | ANASTROZOLE TABLETS | 16 | 0.0007 |
| 8 | LETROZOLE TABLETS | 30 | 0.0006 |
| 9 | LETROZOLE | 33 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 50 |
| 1 | Kinase Inhibitor [EPC] | 39 |
| 2 | Estrogen Receptor Antagonist [EPC] | 29 |
| 3 | RANK Ligand Inhibitor [EPC] | 29 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 24 |
| 5 | Corticosteroid [EPC] | 18 |
| 6 | Microtubule Inhibitor [EPC] | 17 |
| 7 | Opioid Agonist [EPC] | 16 |
| 8 | Alkylating Drug [EPC] | 15 |
| 9 | Provitamin D2 Compound [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 2 | Estrogen Receptor Antagonist [EPC] | 29 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 4 | Aromatase Inhibitor [EPC] | 50 | 0.0004 |
| 5 | Cannabinoid [EPC] | 2 | 0.0002 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 11 | 0.0001 |
| 7 | RANK Ligand Inhibitor [EPC] | 29 | 0.0001 |
| 8 | Stimulant Laxative [EPC] | 2 | 0.0001 |
| 9 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |